Because the E-cadherin–regulating transcription factors SLUG and N-cadherin promote gefitinib resistance [26,31], we investigated the link between folate disruption and the acquisition of drug resistance in NSCLC cells. Here, SNAI2 is linked to non-small cell lung carcinoma.